Related Experiment Videos
Expanding uses of octreotide
1Oklahoma Foundation for Digestive Research, OK City 73104.
Bailliere'S Clinical Gastroenterology
|June 1, 1994
Summary
Octreotide effectively manages various pancreatic disorders, including pancreatitis and fistulae, and intestinal issues like motility disorders and refractory diarrhea. Further controlled studies are needed to fully establish its therapeutic potential.
Area of Science:
- Gastroenterology
- Endocrinology
- Surgical Oncology
Background:
- Octreotide is a synthetic analog of somatostatin.
- Its therapeutic applications span multiple gastrointestinal and pancreatic conditions.
Purpose of the Study:
- To review the therapeutic uses of octreotide in pancreatic disorders.
- To assess octreotide's efficacy in various intestinal motility and secretion disorders.
- To briefly cover octreotide's role in neuroendocrine tumors.
Main Methods:
- Literature review of studies on octreotide's clinical applications.
- Evaluation of evidence for octreotide in pancreatitis, fistulae, and motility disorders.
- Brief discussion of octreotide in neuroendocrine tumor therapy and imaging.
Main Results:
- Octreotide shows potential in managing acute and postoperative pancreatitis, pancreatic fistulae, and chronic pancreatitis symptoms.
- It is also reviewed for use in gastrointestinal bleeding, intestinal fistulae, and refractory diarrhea.
- Limited controlled studies exist for many applications, impacting definitive conclusions.
Conclusions:
- Octreotide demonstrates therapeutic utility across a range of pancreatic and intestinal conditions.
- Further rigorous, controlled clinical trials are necessary to fully ascertain octreotide's benefits and optimize its use.
- Its role in neuroendocrine tumors warrants continued investigation for therapy and diagnostics.